Viral Screening with VDRL

Key Aspects of HIV-1/2 Antibody Testing

• Purpose: These tests determine if a person has been infected with HIV, identifying antibodies produced by the immune system.
• HIV-1 vs. HIV-2: HIV-1 is the most common type worldwide, while HIV-2 is more commonly found in West Africa and tends to progress slower.
• 4th Generation Tests: Preferred for testing, these detect both HIV antibodies and the p24 antigen, allowing for earlier detection (often within 2-6 weeks of exposure).
• Rapid Tests: These provide quick results, usually within 20 minutes, used in clinics and rapid-testing scenarios.
• Screening Procedures:
  • Reactive (Positive): Indicates HIV-1/2 antibodies were found; further testing is needed to confirm the diagnosis.
  • Non-Reactive (Negative): Indicates no antibodies were found. A follow-up test may be recommended depending on the timing of the last exposure.

When to Test

• Routine screenings are recommended for adults aged 13-64.
• Testing is critical following possible exposure (unprotected sex, shared needles).
• Symptoms such as fever, rash, swollen lymph nodes, or persistent fatigue should warrant a test.

Key Facts About HBsAg Screening:

• Purpose: To detect and screen for HBV infection, or to monitor chronic Hepatitis B.
• Sample Type: A blood sample is taken from a vein, and results are generally available in 1-3 days.
• Testing Protocol: If positive, further tests are required to determine if the infection is new (acute) or chronic, as treatment differs for each.
• CDC Recommendation: The CDC recommends that all adults (18+) get tested for hepatitis B at least once in their lifetime.
• What it does NOT detect: A positive HBsAg test does not distinguish between acute and chronic infections on its own, nor does it indicate immunity (which is measured by the Anti-HBs / HBsAb test)

The HCV antibody test (Anti-HCV) is a blood test that detects if your immune system has produced antibodies against the hepatitis C virus. A positive (reactive) result indicates past or present exposure to the virus but does not confirm an active infection. A positive result requires a follow-up HCV RNA confirmatory test to determine if the virus is currently active.

Key Details Regarding VDRL/RPR Tests:

• Purpose: The tests screen for syphilis, a sexually transmitted infection (STI), and can monitor treatment effectiveness.
• Procedure: A blood sample is taken, usually with no special preparation required (e.g., no fasting).
• Result Interpretation:
  • Negative/Nonreactive: Usually indicates no syphilis, or that the infection is in the very early stage.
  • Positive/Reactive: Suggests a syphilis infection, but it can also be a false positive (biologic false positive) due to other illnesses (e.g., HIV, lupus, pregnancy, malaria).
• Follow-up: Positive RPR/VDRL results must be confirmed with a treponemal test, such as the FTA-ABS (Fluorescent Treponemal Antibody Absorption) test, which specifically detects antibodies to T. pallidum.

Difference Between VDRL and RPR:

• VDRL (Venereal Disease Research Laboratory): Can be used on both blood serum and cerebrospinal fluid (CSF) to diagnose neurosyphilis.
• RPR (Rapid Plasma Reagin): Generally used for blood screening; it is more automated, faster, and does not require microscopic evaluation.

Key Considerations:

• Testing Recommendations: Routine testing is recommended for pregnant women as part of prenatal care, and for sexually active individuals with multiple partners.
• Symptoms: Doctors may prescribe this test if a patient shows symptoms like sores, rashes, or fever.